Castillo JJ - Search Results

1

New treatment strategies for Waldenström macroglobulinemia.

Moreno DF, de Larrea CF, Castillo JJ. Moreno DF, et al. Among authors: castillo jj. Clin Adv Hematol Oncol. 2022 Aug;20(8):506-515. Clin Adv Hematol Oncol. 2022. PMID: 36125957 Review.

2

Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Xu L, Hunter ZR, Yang G, Cao Y, Liu X, Manning R, Tripsas C, Chen J, Patterson CJ, Kluk M, Kanan S, Castillo J, Lindeman N, Treon SP. Xu L, et al. Leukemia. 2014 Aug;28(8):1698-704. doi: 10.1038/leu.2014.65. Epub 2014 Feb 10. Leukemia. 2014. PMID: 24509637

3

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia.

Treon SP, Tripsas CK, Meid K, Kanan S, Sheehy P, Chuma S, Xu L, Cao Y, Yang G, Liu X, Patterson CJ, Warren D, Hunter ZR, Turnbull B, Ghobrial IM, Castillo JJ. Treon SP, et al. Among authors: castillo jj. Blood. 2014 Jul 24;124(4):503-10. doi: 10.1182/blood-2014-03-566273. Epub 2014 May 23. Blood. 2014. PMID: 24859363 Free article. Clinical Trial.

4

The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia.

Cao Y, Hunter ZR, Liu X, Xu L, Yang G, Chen J, Patterson CJ, Tsakmaklis N, Kanan S, Rodig S, Castillo JJ, Treon SP. Cao Y, et al. Among authors: castillo jj. Leukemia. 2015 Jan;29(1):169-76. doi: 10.1038/leu.2014.187. Epub 2014 Jun 10. Leukemia. 2015. PMID: 24912431

5

Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database.

Castillo JJ, Olszewski AJ, Cronin AM, Hunter ZR, Treon SP. Castillo JJ, et al. Blood. 2014 Jun 19;123(25):3999-4000. doi: 10.1182/blood-2014-05-574871. Blood. 2014. PMID: 24948623 Free article. No abstract available.

6

Waldenström macroglobulinemia.

Treon SP, Hunter ZR, Castillo JJ, Merlini G. Treon SP, et al. Among authors: castillo jj. Hematol Oncol Clin North Am. 2014 Oct;28(5):945-70. doi: 10.1016/j.hoc.2014.06.003. Epub 2014 Aug 5. Hematol Oncol Clin North Am. 2014. PMID: 25212891 Review.

7

Extramedullary Waldenström macroglobulinemia.

Banwait R, Aljawai Y, Cappuccio J, McDiarmid S, Morgan EA, Leblebjian H, Roccaro AM, Laubach J, Castillo JJ, Paba-Prada C, Treon S, Redd R, Weller E, Ghobrial IM. Banwait R, et al. Among authors: castillo jj. Am J Hematol. 2015 Feb;90(2):100-4. doi: 10.1002/ajh.23880. Epub 2014 Nov 19. Am J Hematol. 2015. PMID: 25349134 Free article.

8

CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenström macroglobulinaemia cells.

Cao Y, Hunter ZR, Liu X, Xu L, Yang G, Chen J, Tsakmaklis N, Kanan S, Castillo JJ, Treon SP. Cao Y, et al. Among authors: castillo jj. Br J Haematol. 2015 Mar;168(5):701-7. doi: 10.1111/bjh.13200. Epub 2014 Nov 5. Br J Haematol. 2015. PMID: 25371371 Free article.

9

Biology, prognosis, and therapy of Waldenström Macroglobulinemia.

Castillo JJ, Ghobrial IM, Treon SP. Castillo JJ, et al. Cancer Treat Res. 2015;165:177-95. doi: 10.1007/978-3-319-13150-4_7. Cancer Treat Res. 2015. PMID: 25655610 Review.

10

Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia.

Leblebjian H, Noonan K, Paba-Prada C, Treon SP, Castillo JJ, Ghobrial IM. Leblebjian H, et al. Among authors: castillo jj. Am J Hematol. 2015 Jun;90(6):E122-3. doi: 10.1002/ajh.23985. Epub 2015 May 10. Am J Hematol. 2015. PMID: 25703132 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

368 results

Search Page